The popularity of Sildenafil initially sparked a surge for the drug industry, but recent developments present a murky picture for investors. Off-patent alternatives are reducing earnings, and ongoing patent challenges https://abelizga369166.acidblog.net/72431585/viagra-and-big-pharma-a-volatile-bet